PharmX Technologies (PHX) investor relations material

Platform and business overview

• Operates a single platform connecting 99% of ANZ pharmacies, processing over $26bn in network volume annually.

• Relay and Gateway EDI provide a modern, scalable infrastructure with fixed and variable fees, supporting both upstream and downstream supply chain flows.

• Marketplace enables multi-supplier ordering, live stock and pricing, and analytics, with over 2,000 pharmacies registered in 10 months.

• Strategic alliance with Sigma includes a 10% equity stake and board representation, accelerating revenue and market expansion.

• Data and analytics services deliver supply chain intelligence, with over 500 million document lines processed annually.

Financial and operational performance

• FY26 revenue reached $7.74m, up 3% YoY, with positive EBITDA of $1.1m and a strong cash position of $2.6m.

• Gross margin rose to 84%, and base business EBITDA margin exceeded 40%.

• Marketplace recurring revenue grew 73%, Gateway revenue increased 8%, and New Zealand revenue rose 67% YoY.

• Total GTV grew 11% YoY, with ARPU increases across Gateway (+10%), Marketplace (+69%), and Analytics (+12%).

• Supplier transition to the single platform improved 13% YoY, supporting higher-value services and new revenue models.

Strategic focus and growth initiatives

• FY27 targets double-digit revenue growth at cashflow breakeven, with 88% of revenue recurring or contracted.

• Supplier growth objectives include EDI Relay rollout in NZ and AU, targeting $700k ARR and $6bn serviceable GTV.

• Marketplace aims for a $120m annualised GTV run rate and a pathway to $1bn GTV, supported by new product innovations.

• Expansion into hospital distribution and enhanced pharmacy tools are planned, with a target of 3,000 new EDI Gateway accounts.

• Strategic partnerships and AI-driven efficiencies are key enablers for scaling and margin expansion.